US Patent Issued to Liquid Biopsy Research on July 22 for "Chemical compositions and methods of use" (British, American Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,366,575, issued on July 22, was assigned to Liquid Biopsy Research LLC (Charlestown, Saint Kitts and Nevis).

"Chemical compositions and methods of use" was invented by Irvin Mark Modlin (Woodbridge, Conn.), Mark Kidd (New Haven, Conn.) and Ignat Drozdov (Stratford Upon Avon, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to methods for detecting a plasma cell dyscrasia like myeloma or MGUS, methods for determining whether a plasma cell dyscrasiais stable or progressive, methods for determining a risk for disease relapse, and methods for determining a response by a subject having a plasma cell dyscrasia to ...